Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5-HTSEP: Serotonin 5-HT7 Receptor Implication in the Inflammatory Mechanisms in Multiple Sclerosis

NCT04546698 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.

NCT NCT04546698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5-HTSEP: Serotonin 5-HT7 Receptor Implication in the Inflammatory Mechanisms in Multiple Sclerosis
Lead sponsor
Centre Hospitalier Régional d'Orléans
Phase
Observational
Overall status
Completed
Start date
September 7, 2020
Completion date
July 19, 2021
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis, acute relapsing